JPS5253841A - Process for manufacture of intermediates of substituted omegaapentanolprostaglandins - Google Patents

Process for manufacture of intermediates of substituted omegaapentanolprostaglandins

Info

Publication number
JPS5253841A
JPS5253841A JP51123737A JP12373776A JPS5253841A JP S5253841 A JPS5253841 A JP S5253841A JP 51123737 A JP51123737 A JP 51123737A JP 12373776 A JP12373776 A JP 12373776A JP S5253841 A JPS5253841 A JP S5253841A
Authority
JP
Japan
Prior art keywords
omegaapentanolprostaglandins
intermediates
substituted
manufacture
substituted omegaapentanolprostaglandins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP51123737A
Other languages
Japanese (ja)
Inventor
Shin Bindora Jiyashitsuto
Rosu Jiyonson Maikeru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of JPS5253841A publication Critical patent/JPS5253841A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40Esters thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
JP51123737A 1972-11-08 1976-10-15 Process for manufacture of intermediates of substituted omegaapentanolprostaglandins Pending JPS5253841A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30481372A 1972-11-08 1972-11-08

Publications (1)

Publication Number Publication Date
JPS5253841A true JPS5253841A (en) 1977-04-30

Family

ID=23178133

Family Applications (3)

Application Number Title Priority Date Filing Date
JP12527273A Expired JPS5416491B2 (en) 1972-11-08 1973-11-07
JP51123737A Pending JPS5253841A (en) 1972-11-08 1976-10-15 Process for manufacture of intermediates of substituted omegaapentanolprostaglandins
JP51123738A Pending JPS5257147A (en) 1972-11-08 1976-10-15 Process for preparing omegaasubstituted pentanor prostagladines intermediates

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP12527273A Expired JPS5416491B2 (en) 1972-11-08 1973-11-07

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP51123738A Pending JPS5257147A (en) 1972-11-08 1976-10-15 Process for preparing omegaasubstituted pentanor prostagladines intermediates

Country Status (29)

Country Link
JP (3) JPS5416491B2 (en)
AR (3) AR200585A1 (en)
AT (3) AT367034B (en)
AU (1) AU470375B2 (en)
BE (1) BE806995A (en)
CA (3) CA1085831A (en)
CH (1) CH597176A5 (en)
CS (3) CS182793B2 (en)
DD (4) DD118856A5 (en)
DE (1) DE2355540C2 (en)
DK (1) DK144247C (en)
ES (3) ES420325A1 (en)
FI (1) FI60389C (en)
FR (3) FR2205335B1 (en)
GB (3) GB1456514A (en)
HK (3) HK28179A (en)
HU (3) HU172703B (en)
IE (1) IE39537B1 (en)
IL (1) IL43589A (en)
IN (1) IN139384B (en)
KE (3) KE2930A (en)
MY (3) MY7900246A (en)
NL (1) NL164273C (en)
NO (3) NO147836C (en)
PH (3) PH13272A (en)
SE (4) SE448992B (en)
SU (4) SU584766A3 (en)
YU (3) YU39715B (en)
ZA (1) ZA738554B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001515885A (en) * 1997-09-09 2001-09-25 ザ プロクター アンド ギャンブル カンパニー Aromatic C16-C20 substituted tetrahydroprostaglandins useful as FP agonists
US9675539B2 (en) 2000-03-31 2017-06-13 Duke University Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
US3986764A (en) * 1975-03-31 1976-10-19 Gte Automatic Electric Laboratories Incorporated Panel for supporting a pair of elongated mating connectors and selectively locking them together
GB1506816A (en) * 1975-03-31 1978-04-12 Upjohn Co Prostaglandins
ES449162A1 (en) * 1975-06-23 1977-12-16 Syntex Inc 16-Phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives
GB1516414A (en) * 1975-08-22 1978-07-05 Ici Ltd Prostane derivatives
SE7809008L (en) * 1977-12-12 1979-06-13 Upjohn Co USE OF PROSTAGLAND TYPE AMIDES TO CONTROL OR REGULATE THE REPRODUCTION CYCLE IN INDIVIDUALS OF MAMMALS
DK523378A (en) * 1978-01-16 1979-07-17 Pfizer PROCEDURE FOR THE PREPARATION OF N- (TETRAZOL-5-YL) PROSTAGLANDIN CARBOXAMIDES OR SALTS THEREOF
PL350917A1 (en) 1999-03-05 2003-02-10 Procter & Gamble C16 unsaturated fp-selective prostaglandins analogs
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
JP2002329615A (en) * 2001-05-02 2002-11-15 Ohira Denshi Kk Toroidal coil
US6476064B1 (en) * 2001-06-13 2002-11-05 Allergan, Inc. Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents
WO2006047466A2 (en) 2004-10-21 2006-05-04 Duke University Ophthamological drugs
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1324737A (en) * 1970-11-02 1973-07-25 Upjohn Co Prostaglandins and the preparation thereof
IE37602B1 (en) * 1971-05-11 1977-08-31 Ici Ltd Cyclopentane derivatives

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001515885A (en) * 1997-09-09 2001-09-25 ザ プロクター アンド ギャンブル カンパニー Aromatic C16-C20 substituted tetrahydroprostaglandins useful as FP agonists
JP2010254705A (en) * 1997-09-09 2010-11-11 Duke Univ Aromatic c16-c20 substituted tetrahydro prostaglandins useful as fp agonists
US9675539B2 (en) 2000-03-31 2017-06-13 Duke University Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives

Also Published As

Publication number Publication date
AT353285B (en) 1979-11-12
CS182793B2 (en) 1978-05-31
YU37316B (en) 1984-08-31
HU172703B (en) 1978-11-28
MY7900245A (en) 1979-12-31
HK28179A (en) 1979-05-11
IE39537L (en) 1974-05-08
DE2365322B2 (en) 1977-02-24
NL164273C (en) 1980-12-15
MY7900243A (en) 1979-12-31
SU584766A3 (en) 1977-12-15
PH13272A (en) 1980-02-27
CA1088931A (en) 1980-11-04
IN139384B (en) 1976-06-12
YU270680A (en) 1983-04-27
SE431756B (en) 1984-02-27
FR2205335B1 (en) 1978-07-13
GB1456514A (en) 1976-11-24
JPS4993342A (en) 1974-09-05
FR2279729A1 (en) 1976-02-20
MY7900246A (en) 1979-12-31
FR2283146A1 (en) 1976-03-26
FI60389B (en) 1981-09-30
KE2930A (en) 1979-03-30
AU6224773A (en) 1975-05-08
NO148998C (en) 1984-01-25
FR2205335A1 (en) 1974-05-31
AR199966A1 (en) 1974-10-08
HU173507B (en) 1979-05-28
CH597176A5 (en) 1978-03-31
DD109212A5 (en) 1974-10-20
ES420325A1 (en) 1976-04-16
SU745362A3 (en) 1980-06-30
YU288073A (en) 1982-02-28
CA1085831A (en) 1980-09-16
YU270780A (en) 1982-06-18
HK28079A (en) 1979-05-11
FI60389C (en) 1982-01-11
SU667141A3 (en) 1979-06-05
SE448992B (en) 1987-03-30
JPS5416491B2 (en) 1979-06-22
NO147836B (en) 1983-03-14
ATA544576A (en) 1980-06-15
IL43589A (en) 1980-01-31
ATA544676A (en) 1979-04-15
DD119411A5 (en) 1976-04-20
IE39537B1 (en) 1978-11-08
ES433047A1 (en) 1976-11-01
CS182791B2 (en) 1978-05-31
ZA738554B (en) 1974-09-25
NO743493L (en) 1974-05-09
ATA936973A (en) 1981-10-15
YU39715B (en) 1985-04-30
YU36975B (en) 1984-08-31
CS182794B2 (en) 1978-05-31
NO149139B (en) 1983-11-14
AT367034B (en) 1982-05-25
NO750535L (en) 1974-05-09
PH13110A (en) 1979-11-28
JPS5257147A (en) 1977-05-11
NL7315263A (en) 1974-05-10
CA1088930A (en) 1980-11-04
HK27979A (en) 1979-05-11
DD117233A5 (en) 1976-01-05
SE7700716L (en) 1977-01-24
SU893130A3 (en) 1981-12-23
NO147836C (en) 1983-06-22
GB1456512A (en) 1976-11-24
AU470375B2 (en) 1976-03-11
KE2932A (en) 1979-03-30
SE436278B (en) 1984-11-26
NO148998B (en) 1983-10-17
HU171819B (en) 1978-03-28
DK144247C (en) 1982-07-12
PH13325A (en) 1980-03-13
DD118856A5 (en) 1976-03-20
KE2931A (en) 1979-03-30
SE7700717L (en) 1977-01-24
DK144247B (en) 1982-01-25
AR200585A1 (en) 1974-11-22
BE806995A (en) 1974-05-07
DE2365322A1 (en) 1974-11-07
AT360672B (en) 1981-01-26
ES433046A1 (en) 1977-06-16
FR2279729B1 (en) 1978-04-28
AR202931A1 (en) 1975-07-31
SE7700718L (en) 1977-01-24
DE2355540C2 (en) 1982-11-18
NO149139C (en) 1984-02-29
FR2283146B1 (en) 1981-06-19
DE2355540A1 (en) 1974-05-22
SE445111B (en) 1986-06-02
IL43589A0 (en) 1974-03-14
GB1456513A (en) 1976-11-24

Similar Documents

Publication Publication Date Title
JPS52142045A (en) Process for manufacture of cyclopropane derivatives
JPS5253841A (en) Process for manufacture of intermediates of substituted omegaapentanolprostaglandins
ZA739156B (en) Process for the production of dimethyl-ether
YU3373A (en) Process for obtaining substituted derivatives of piperidinoalkanone-oximes
CH614188A5 (en) Process for the preparation of novel aminophenylethanolamines
KR780000002B1 (en) Process for the production of saccarase inhibitor
JPS52122349A (en) Process for preparing tntermediate of 155substituteddomegaa pentanoprostagladines
EG11014A (en) Improved process for production of propylene
CS183721B2 (en) Method of production of alfa-aminoacylcephalosporines
YU41547B (en) Process for obtaining new derivatives of p-dyhydroxibenzen-disuephonic acid
EG11434A (en) Process for the manufacture of n-benzhydryl-n-p-hydroxybenzyl-piperazines
HK62977A (en) Process for the manufacture of triacetone-amine
GB1402501A (en) Process for the production of 4-nitroso-diphenylamine
YU36925B (en) Process for obtaining silylesters of acetidine-2-sulfenate
EG11021A (en) Process for preparing of new penicillins
EG11062A (en) Process for preparing of new penicillins
ZA737876B (en) Improved process for the production of coated roadstone
CH614430A5 (en) Process for the preparation of substituted phenylguanidines
YU299579A (en) Process for obtaining novel derivatives of aminoimidazoloisoquinoline
YU36724B (en) Process for the manufacture of benzodioxole derivatives
YU19073A (en) Process for the manufacture of cyanoalkylaminopropanes
KR780000001B1 (en) Process for the production of saccarase inhibitor
JPS56108784A (en) Manufacture of novel 22aminoo4hhpyrane compound
GB1405218A (en) Process for the manufacture of 2-aryl-v-triazoles
JPS5231054A (en) Process for manufacture of intermediates of prostaglandin homologs